Rankings
▼
Calendar
LXRX Q1 2016 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$693M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
Gross Profit
-$25M
-196.2% margin
Operating Income
-$34M
-271.1% margin
Net Income
-$35M
-279.2% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-90.2%
Cash Flow
Operating Cash Flow
-$44M
Free Cash Flow
-$44M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$611M
Total Liabilities
$358M
Stockholders' Equity
$253M
Cash & Equivalents
$477M
← FY 2016
All Quarters
Q2 2016 →
